HC Wainwright maintains $16.00 Fennec Pharmaceuticals price target
HC Wainwright & Co. maintained its $16.00-per-share price target on Fennec Pharmaceuticals, per Benzinga ratings actions.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.